Worse still, if you'd only held Zoetis stock for the past one, or three, or five years, you would have lost money. Zoetis ...

Despite Zoetis' underperformance relative to the broader market over the past year, Wall Street analysts maintain a bullish ...

These two stocks come from completely different industries, but each could boost a long-term investor's returns.

Zoetis Inc. (NYSE:ZTS) is one of the best defensive stocks to invest in according to analysts. On July 10, Bank of America ...

The global Veterinary Diagnostics Market, valued at US$3.42 billion in 2024 stood at US$3.68 billion in 2025 and is projected to advance at a ...

The global Veterinary Diagnostics Market, valued at US$3.42 billion in 2024 stood at US$3.68 billion in 2025 and is projected ...

In addition to TD Cowen, Zoetis also received a Buy from William Blair’s Brandon Vazquez in a report issued today. However, on July 31, Stifel Nicolaus maintained a Hold rating on Zoetis (NYSE: ZTS).

Hypnotic Video of GIGANTIC US Aircraft Carriers in the Middle of the Sea 'Alligator Alcatraz' migrant detention camp in ...

Animal health firm Zoetis Inc. (NYSE:ZTS) on Tuesday reported a second-quarter 2025 adjusted earnings per share of $1.76, up ...

Zoetis Inc. Q2 2025 earnings highlight 8% organic revenue growth, raised guidance, and strong performance from Simparica and Key Dermatology franchises.

Zoetis (ZTS) stock surges premarket as the company posts strong Q2 2025 results and raises full-year outlook. Read more here.